Trials / Sponsors / Medigene AG
Medigene AG
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovar Epithelial Ovarian Cancer, Gastro-esophageal Junction Cancer, Soft Tissue Sarcoma (STS) | Phase 1 | 2025-07-01 |
| Withdrawn | HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2020-07-02 |
| Terminated | TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms Safety, Tolerability, Feasibility | Phase 1 / Phase 2 | 2018-03-27 |
| Completed | DC Vaccination for Post-remission Therapy in AML Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2015-03-01 |